Belpointe Asset Management’s BlackRock Health Sciences Trust II BMEZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-975
Closed -$16.3K 915
2023
Q1
$16.3K Buy
975
+675
+225% +$10.9K ﹤0.01% 2432
2022
Q4
$4.63K Buy
+300
New +$4.64K ﹤0.01% 2964

Other funds holding BMEZ

Belpointe Asset Management's BMEZ Position: Q2 2023 in Review

Belpointe Asset Management sold out of BlackRock Health Sciences Trust II (BMEZ) in Q2 2023, closing a stake of 975 shares — an estimated $16.3K sold.

Belpointe Asset Management first reported a position in BMEZ in Q4 2022 and held it in 2 quarters. The position peaked at $16.3K in Q1 2023. 91 funds tracked by Wall St. Rank hold BMEZ as of Q2 2023.

  • Belpointe Asset Management reported no remaining BlackRock Health Sciences Trust II position as of Q2 2023 after selling out during the quarter.
  • Belpointe Asset Management sold 975 BlackRock Health Sciences Trust II shares in Q2 2023, an estimated $16.3K.
  • Belpointe Asset Management first reported a position in BlackRock Health Sciences Trust II in Q4 2022 and held it in 2 quarters.
  • Belpointe Asset Management's BlackRock Health Sciences Trust II position peaked at $16.3K in Q1 2023.
  • 91 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust II as of Q2 2023.

Based on Belpointe Asset Management's 13F filing for Q2 2023, filed 15 Aug 2023.